Theravance Biopharma, Inc. Stock Issued During Period, Value, Restricted Stock Award, Gross
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Theravance Biopharma, Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2025-12-31 was $0.00.
- Theravance Biopharma, Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2025-09-30 was $0.00.
- Theravance Biopharma, Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2025-06-30 was $0.00.
- Theravance Biopharma, Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2025-03-31 was $1.00K.
- Theravance Biopharma, Inc. stock issued during period, value, restricted stock award, gross for fiscal 2025 was $1.00K.
- Theravance Biopharma, Inc. stock issued during period, value, restricted stock award, gross for fiscal 2017 was $0.00.
- Theravance Biopharma, Inc. stock issued during period, value, restricted stock award, gross for fiscal 2016 was $0.00.
- Theravance Biopharma, Inc. stock issued during period, value, restricted stock award, gross for fiscal 2015 was $0.00.
| Period end | Stock Issued During Period, Value, Restricted Stock Award, Gross 3 month | Stock Issued During Period, Value, Restricted Stock Award, Gross 12 month |
|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $1.00K 10-K · filed 2026-03-23 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | |
| 2025-03-31 | $1.00K 10-Q · filed 2026-05-07 | |
| 2017-12-31 | $0.00 10-K · filed 2018-02-28 | |
| 2016-12-31 | $0.00 10-K · filed 2018-02-28 | |
| 2015-12-31 | $0.00 10-K · filed 2018-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |